Misdiagnosis of Infiltrating Adenocarcinoma in Bronchiolar Adenoma Pathological Features and Frozen Section Challenges
This paper presents a case of a 67-year-old female where a bronchiolar adenoma was initially misdiagnosed as infiltrating adenocarcinoma during intraoperative frozen section analysis, highlighting the diagnostic challenges and emphasizing the importance of recognizing dual-layer glandular structures and basal cell marker positivity to differentiate this benign tumor from malignant mimics.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the quiet landscape of the human lung, a new kind of growth has recently come into focus, challenging the way doctors distinguish between harmless lumps and dangerous cancers. For decades, pathologists have relied on specific visual clues to tell a benign tumor from a malignant one, looking for signs of invasion and cellular chaos. However, a newly recognized type of benign tumor, known as a bronchiolar adenoma, mimics the appearance of cancer so closely that it can easily trick even experienced eyes. This tumor, which was formally defined only a few years ago, grows in the tiny airways of the lung and is composed of two distinct layers of cells: a protective outer layer and an inner layer that lines the airway. While it is harmless, its ability to look like a deadly cancer on scans and under a microscope creates a significant dilemma for surgeons, who must decide in the operating room whether to remove a small piece of tissue or an entire lobe of the lung.
The story of this diagnostic challenge comes from a 67-year-old woman who arrived at a hospital seeking help for a renal cyst. During a routine scan of her body, doctors discovered a small, solid nodule in the upper part of her left lung. The spot was about the size of a large grape, measuring 14 millimeters by 11 millimeters. What made the finding particularly concerning was that the nodule had a small hollow space inside it and seemed to be pulling on the nearby lung lining, a feature often seen in aggressive cancers. Because the imaging suggested a high risk of malignancy, the medical team proceeded with surgery to remove the upper part of her left lung. During the operation, a critical moment occurred: a pathologist examined a tiny sample of the nodule under a microscope while the patient was still on the operating table. This quick analysis, known as a frozen section, is designed to give surgeons an immediate answer so they can decide how much tissue to remove. In this case, the pathologist saw features that looked like an invasive cancer and reported that the tumor was malignant.
Based on that immediate report, the surgeons performed a full removal of the left upper lung lobe and cleared nearby lymph nodes, a standard and necessary procedure for lung cancer. However, once the surgery was complete, the tissue was sent for a more thorough, detailed examination that takes several days. When the pathologists looked at the preserved tissue with high magnification, the picture changed completely. They saw that the tumor was not a chaotic, invading cancer at all. Instead, it had a very orderly structure. The cells were arranged in neat, double-layered tubes, with a continuous outer layer of cells that acted as a protective barrier. Inside the tubes, they found cells with tiny, hair-like projections called cilia, which are a hallmark of healthy airway lining. Furthermore, the tumor did not show the frantic cell division or the jagged, invasive edges typical of cancer. It was growing around the blood vessels and airways in a way that suggested it was pushing them aside rather than eating into them.
To confirm this new understanding, the team used special stains that act like highlighters for specific cell types. These tests showed that the outer layer of the tumor cells was positive for markers that identify basal cells, the stem-like cells that form the foundation of the airway lining. This finding was the smoking gun that ruled out cancer, as malignant tumors of this type lack this continuous protective layer. The final diagnosis was revised to a distal-type bronchiolar adenoma, a benign tumor that had been misidentified as an infiltrating adenocarcinoma. The patient recovered well, and a follow-up scan a month later showed no signs of the tumor returning.
This case highlights a specific and difficult problem in modern medicine: the gap between what a pathologist sees in a rush and what is revealed in a careful, final review. The initial error happened because the frozen tissue sample was small and the tumor had some features that overlap with cancer, such as the hollow space inside and the way it pulled on the lung lining. The pathologist, seeing these signs in a hurry, correctly identified the danger but missed the subtle clues of the benign nature, such as the double-layered structure and the presence of ciliated cells. The authors of this report emphasize that while the final diagnosis is usually clear once the tissue is fully processed, the pressure of the operating room makes these mistakes more likely. They note that this type of tumor is still relatively new to the medical community, and many pathologists have not yet seen enough cases to recognize its unique patterns instantly.
The lesson from this patient's journey is not that the surgery was wrong, but that the world of lung nodules contains rare, tricky mimics that require patience and detailed study to identify correctly. The tumor itself was a benign growth that, despite its scary appearance on the scan and its deceptive look under the microscope, posed no threat of spreading. The medical team's ability to catch the error after the surgery and reclassify the tumor ensures that the patient receives the correct long-term care, which for a benign tumor is simply observation rather than aggressive treatment. As more cases are studied and pathologists gain experience with this specific type of growth, the hope is that these intraoperative misdiagnoses will become less frequent, allowing for even more precise and less invasive care for patients with lung nodules.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.